Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1363035 | 0.84 | MEN1 (0.36) | ARPGRNR3C1MEN1KMT2A | |
| SCHEMBL1364749 | 0.84 | MEN1 (0.36) | ARPGRNR3C1MEN1KMT2A | |
| SCHEMBL1365838 | 0.84 | AR (0.35) | ARPGR | |
| SCHEMBL27236963 | 0.78 | AR (0.40) | ARPGRNR3C1 | |
| SCHEMBL1365692 | 0.75 | AR (0.44) | ARPGR | |
| SCHEMBL1365015 | 0.74 | AR (0.42) | ARPGRNR3C1 | |
| SCHEMBL1365013 | 0.74 | AR (0.42) | ARPGRNR3C1 | |
| SCHEMBL1363750 | 0.74 | PGR (0.58) | ARPGR | |
| SCHEMBL1368160 | 0.74 | PGR (0.58) | ARPGR | |
| SCHEMBL15663226 | 0.74 | PGR (0.58) | ARPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2260028-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | Radius Health, Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| WO-2009105214-A2 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | RADIUS HEALTH, INC. (US) | 2009-08-27 | — | — | WO | disclosed |